Trial Profile
Study Assessing Efficacy of Golimumab in Patients with Rheumatoid Arthritis Previously Treated with Conventional Synthetic Disease Modifying Antirheumatics drugs (csDMARDs) or Biological DMARDs (bDMARDs) (Italian Lorhen Registry)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Aug 2016
Price :
$35
*
At a glance
- Drugs Golimumab (Primary) ; Ciclosporin; Leflunomide; Methotrexate; Prednisone; Sulfasalazine
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 30 Aug 2016 New trial record